...
首页> 外文期刊>Human Molecular Genetics >Distal enhancers upstream of the Charcot-Marie-Tooth type 1A disease gene PMP22
【24h】

Distal enhancers upstream of the Charcot-Marie-Tooth type 1A disease gene PMP22

机译:Charcot-Marie-Tooth 1A型疾病基因PMP22上游的远端增强子

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Myelin insulates axons in the peripheral nervous system to allow rapid propagation of action potentials, and proper myelination requires the precise regulation of genes encoding myelin proteins, including PMP22. The correct gene dosage of PMP22 is critical; a duplication of PMP22 is the most common cause of the peripheral neuropathy Charcot-Marie-Tooth Disease (CMT) (classified as type 1A), while a deletion of PMP22 leads to another peripheral neuropathy, hereditary neuropathy with liability to pressure palsies. Recently, duplications upstream of PMP22, but not containing the gene itself, were reported in patients with CMT1A like symptoms, suggesting that this region contains regulators of PMP22. Using chromatin immunoprecipitation analysis of two transcription factors known to upregulate PMP22—EGR2 and SOX10—we found several enhancers in this upstream region that contain open chromatin and direct reporter gene expression in tissue culture and in vivo in zebrafish. These studies provide a novel means to identify critical regulatory elements in genes that are required for myelination, and elucidate the functional significance of non-coding genomic rearrangements.
机译:髓磷脂可隔离周围神经系统的轴突,使动作电位快速传播,而适当的髓鞘形成则需要对编码髓磷脂蛋白(包括PMP22)的基因进行精确调节。 PMP22的正确基因剂量至关重要。 PMP22的重复是引起周围神经病的最常见原因是Charcot-Marie-Tooth病(分类为1A型),而PMP22的缺失会导致另一种周围神经病,即遗传性神经病,与压力性麻痹有关。最近,在患有CMT1A症状的患者中报告了PMP22上游的重复序列,但不包含该基因本身,这表明该区域包含PMP22的调节子。使用已知上调PMP22和EGR2的两个转录因子的染色质免疫沉淀分析,我们在该上游区域发现了几种增强剂,它们在组织培养和斑马鱼体内含有开放的染色质并指导报告基因表达。这些研究提供了新颖的方法来鉴定髓鞘形成所需的基因中的关键调控元件,并阐明非编码基因组重排的功能意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号